Resonance Health Ltd ( (AU:RHT) ) has provided an announcement.
Resonance Health Ltd announced a significant change in the director’s interest in securities, with Director Aaron Brinkworth acquiring a substantial number of ordinary fully paid shares over several days in April 2025. This acquisition increases Brinkworth’s total holdings to over one million shares, indicating a strong vote of confidence in the company’s future prospects and potentially impacting the company’s market perception and stakeholder interests.
More about Resonance Health Ltd
Resonance Health Ltd is a company operating in the healthcare industry, primarily focused on providing medical imaging software and services. The company’s products are designed to assist in the diagnosis and management of liver diseases, with a market focus on improving patient outcomes through advanced imaging technologies.
YTD Price Performance: -20.0%
Average Trading Volume: 408,637
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$16.09M
See more insights into RHT stock on TipRanks’ Stock Analysis page.